Perhaps no industry in healthcare has seen its political fortunes change faster than PBMs over the last two years.
It’s been just more than a year since Democrats in DC focused on the pharma-targeting Inflation Reduction Act and its drug price reforms. Pharmacy benefit managers quickly became the next item on the target list for lawmakers — from both parties — who want to bring down healthcare costs and increase transparency.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.